Company
Vision
Aible Therapeutics envisions a world where people can live free from the fear of dementia
through the fusion of innovative ideas and AI technology
We are developing an integrated digital platform to prevent, diagnose, manage, and treat
neuropsychiatric disorders, aiming to help more people benefit from our service
Aible in Media
History
AugPreparing for collaborative PoCs with a global home appliance company and a leading domestic pharmaceutical company.
Aug‘Spick’ U.S. patent registered
JunBegan confirmatory clinical trials for medical device certification at 8 hospitals
MaySelected for the MUST. CONNECT 2024 Global AC Program
AprSecured a 3-year R&D project from the Korea Dementia Research Center; began developing a multi-biomarker-based dementia screening solution
AprLaunched regular 'Cognimo' classes at local senior welfare centers
AprLaunched paid services for ‘Spick’ at local smart senior centers
FebSigned an MOU with Gwangju Metropolitan City to establish an AI ecosystem
JanCompleted the first clinical trial in Taiwan (331 participants)
DecAcquired KOLAS V&V certification for ‘Spick’
DecReceived approval from the K-FDA for the confirmatory clinical trial protocol for medical device certification
OctSigned an NDA with a leading domestic pharmaceutical company
OctLaunched paid services for ‘Spick’ at senior daycare centers
SepSecured a 2-year R&D project from the Ministry of SMEs and Startups; began developing a drawing-based dementia screening solution.
AugSigned an NDA with a global home appliance company.
Aug‘Spick’ Taiwan patent registered
JunBegan clinical trials in Taiwan for the collection of standard Mandarin speech data
Jun‘Child and adolescent ADHD screening technology based on eye-tracking’ domestic patent registered
May‘Cognimo’ domestic patent registered
AprAcquired GS certification, Grade 1, for ‘Spick’
Apr‘Spick’ advanced version patent registered in South Korea
MarSelected for the Shinhan Square Bridge 2023 AC Progra
MarDrawing-based dementia diagnosis’ patent registered in South Korea
DecSecured additional investment
DecStarted clinical trials for ‘Cognimo’
SepBegan PoC (Proof of Concept) for ‘Spick’ at senior daycare centers
JulSelected for the Daekyo x Kyobo Life Insurance Age-Tech Wave Open Innovation Program
JunAcquired medical device GMP certification for ‘Spick’ from the Ministry of Food and Drug Safety
AprSecured a 3-year R&D project from the Ministry of Health and Welfare; began developing a mental health monitoring and intervention system for children and adolescents
MarSecured a 1-year R&D project from the Ministry of SMEs and Startups; began developing 'Cognimo' for dementia prevention and management DTx
DecSelected for the Taiwan BE Health Ventures Global AC Program
OctSecured seeding investment
Jul‘Spick’ patent registered in South Korea
MaySelected for the Korea Sports Promotion Foundation's Sports Industry AC Program
AprAdvanced to Top 6 in D.Camp IR pitch
MarWon the Grand Prize (Minister’s Award) in the Ministry of Science and ICT’s ‘Innovation ICT Idea Contest’
FebEstablished Aible Therapeutics Co., Ltd.
Collected 1,300 speech data samples and completed the dementia diagnosis algorithm
Began research on speech-based dementia diagnosis
Co-founders
Prof. Kim, Woojun (CSO)
The Catholic Univ. Of Korea Seoul St.Mary's HospitalCheon, Hosang (CXO)
UI·UX ExpertDr. Kim, Jaewon (CTO)
Seoul National University HospitalProf. Lim, Junsik (CTO)
Gachon UniversityAdvisory Group
Dr. Yang, Dongwon
- Seoul St. Mary's Hospital
- Director of Mapo-gu
Dementia Care Center
Dr. Shim, Yongsoo
- Eunpyeong St. Mary's Hospital
- Director of Eunpyeong-gu
Dementia Care Center
Dr. Yoon, Bora
- Seoul St. Mary's Hospital
- Health and welfare Minister's
Award Recipient
Dr. Hong, Yunjung
- Uijeongbu St. Mary's Hospital
- 2020 Paper Award, Korean
Dementia Association
Dr. Jihye, Park
- Eunpyeong St. Mary's Hospital
- Advisor of National
Pension Service